Webuild Announces Acquisition of Australian Clough
February 06, 2023 07:58 ET
|
WeBuild
MILAN, Italy, Feb. 06, 2023 (GLOBE NEWSWIRE) -- After the signing of the deal for the acquisition of assets of the Australian Clough, Pietro Salini, the chief executive officer of Webuild, said in a...
Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch
February 03, 2023 06:00 ET
|
Revive Therapeutics Ltd.
TORONTO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
Misahara Jewelry and Jeffrey Levinson Join Forces and Create a New Category in Fine Luxury Accessories for Women
February 02, 2023 10:00 ET
|
Misahara
NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Designers Lepa Galeb-Roskopp and Jeffrey Levinson have collaborated to create a fully customizable luxury handbag that is both innovative and versatile....
Tines introduces the ability to build apps with its no-code automation platform
January 26, 2023 09:00 ET
|
Tines
With the recent roll-out of features, Tines cements its position as the most innovative automation platform in the security space Tines is revolutionizing information exchange to facilitate a culture...
An Important Step Toward International Post-Pandemic Biological Research Collaboration | CBIS 13th Biennial Meeting
January 18, 2023 14:44 ET
|
Westlake University
Hangzhou, China, Jan. 18, 2023 (GLOBE NEWSWIRE) -- The Chinese Biological Investigators Society 13th Biennial Meeting was held simultaneously Dec. 19-22, 2022, across two satellite sites in China...
PatPat launches its new Valentine’s Day collaboration with MGA Entertainment’s L.O.L. Surprise!™ Brand
January 12, 2023 12:00 ET
|
PatPat
MOUNTAIN VIEW, Calif. and LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- PatPat, a global leading children’s apparel e-commerce brand, is excited to announce the launch of its new L.O.L. Surprise!™...
Matinas BioPharma Announces Collaboration with National Resilience to Explore and Evaluate Novel LNC Platform Delivery Technology for Certain Nucleic Acids
January 12, 2023 07:00 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids...
PanTerra’s Connect Awarded TMCnet Video Conferencing Excellence Award
January 10, 2023 09:20 ET
|
PanTerra Networks
SAN JOSE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- PanTerra Networks announced today that TMC, a global, integrated media company has named Connect as a 2022 TMCnet Video Conferencing Excellence...
HOOKIPA Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine
January 04, 2023 07:00 ET
|
HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Austria, Jan. 04, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapies based on its proprietary arenavirus...
Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity
December 20, 2022 19:01 ET
|
Sosei Group Corporation
PF-07081532 is the first clinical candidate from multi-target drug discovery collaboration to advance into Phase 2 trialsDosing of first subject in Phase 2 trial by Pfizer triggers payment of US$10...